Business Wire

CA-XX-NETWORK

25.1.2022 16:32:05 CET | Business Wire | Press release

Share
Private Messaging App Launches on Quantum Resistant, Decentralized xx network

The world’s first quantum-resistant messaging app, xx messenger , launched on the xx network today. xx messenger allows users to communicate in real time through hundreds of decentralized nodes operating worldwide. The app is available for download on IOS and Android, features group chat as well as photo and audio sharing, and designed for easy use and switching to from legacy messaging apps.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220125005773/en/

Unlike existing messaging apps, xx messenger uses quantum-resistant cryptography to protect message content from decoding and cMix software to obfuscate or shred metadata—information about who sends, when they send, where they send from, and who receives. Randomly selected teams of xx nodes encrypt anonymity sets of 1,000 messages, which are then repeatedly shuffled and have also been encrypted using quantum-resistant cryptography. Information that links senders and receivers is destroyed, preventing third parties from tracking intimate details about the patterns and structure of our lives.

Centralized service providers now surveil and profile the majority of digital users. Our personal information has been marketed, auctioned, and monetized in an ever-increasingly exploitative manner to advertisers and political groups, which use it to micro-target and manipulate consumers or voters. Decentralized platforms offer a unique opportunity to weave the privacy principles of the early internet back into the fabric of the emerging web3 ecosystem. xx messenger is dedicated to protecting and strengthening inalienable privacy rights at the dawn of web3.

  • Existing Message Encryption is not Quantum Resistant: There is general agreement that, within the relevant timeframe, quantum computers will be able to decode communications that have been encrypted using legacy crypto. At that point, messages sent on all other existing messengers, even those with “strong end-to-end encryption,” will be easily retroactively decoded and analyzed by artificial intelligence. Only what has been said using xx messenger will remain private.
  • Only xx Offers Metadata Shredding: All existing mainstream messengers can capture and potentially exploit metadata. Metadata shredding works by sending messages through randomly chosen xx network nodes around the world. Each node changes the order and the encryption before forwarding and then erases any record of what it has done. Each part of the metadata about who is talking to whom is thereby destroyed before any of the parts can even be assembled to trace.
  • Full xx Decentralization: Every message sent on xx messenger travels through five nodes chosen at random from hundreds of xx nodes around the world. There is no centralized entity for governments to coerce, no company to insert spyware or reveal data from its database. The xx network supporting the xx messenger is a distributed, decentralized blockchain, now in mainnet, and is operated on transparent software run by more than 350 independently owned nodes in more than 80 countries. The xx messenger App, is truly a decentralized App (dApp), which means that it operates on a decentralized blockchain autonomously through smart contracts.

The pioneering team behind the creation of the xx messenger developed early practical, anonymous, and verifiable cryptographic systems and is led by renowned cryptographer David Chaum, who proposed and deployed digital currencies, mix networks, permissionless cryptographic solutions, and verifiable voting systems starting in the 1980s.

“Recent privacy concerns have sensitized the public to problems with control of personal information by centralized entities like Facebook. Realizing that their information is being misused by corporate entities, people are now trying to understand how to use cryptography and smartphones to protect themselves and change society in beneficial ways; xx messenger is securely decentralizing private communication the way Bitcoin decentralized finance. Let’s do this right: let’s take control of our own information– and our destiny.” said David Chaum, inventor of electronic cash and founder of xx network.

The xx messenger is available for download on Android and Apple app stores. Please follow us on Twitter and join our Telegram and Discord .

About xx network
xx network is a new type of platform, offering a protected digital sphere through which its users can share ideas and exchange value in a secure and private way. The xx network blockchain relies on a novel quantum-secure consensus algorithm that efficiently achieves linear authenticator complexity and single-block finality, ensuring scaleable consensus-based operations. The network was built by teams led by David Chaum, the Godfather of cryptocurrency.

For more information, please visit https://xx.network/ .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye